Kansas City Royals infielder Miguel Tejada on Wednesday was cleared by Major League Baseball of allegations that he was one of a group of players that received performance enhancing drugs by the now-shuttered Biogenesis clinic in South Florida.
However, MLB's actions did not alter the 105-game suspension Tejada received for use of amphetamines not related to the Biogenesis scandal.
"The Office of the Commissioner investigated all allegations regarding players associated with Anthony Bosch and Biogenesis. The investigation found no violation by Miguel Tejada of the Joint Drug Prevention and Treatment Program."
ESPN reported Tuesday that Tejada had indeed been implicated in the Biogensis scandal, claiming MLH officials chose to pursue the player for his amphetamine use instead of involvement with Biogenesis, even though Biogenesis officials "provided evidence that Tejada had been a customer."
One reason cited by sources was that this was the third time Tejada has been cited for testing positive for amphetamine use.
Tejada, 39, has said he had a therapeutic use exemption to use the drug Adderall, but the exemption expired in April. The players union claims Tejada should have been allowed to play while he sought an extension to use Adderall, but he chose not to and has not appealed or fought the suspension.
Tejada has played in a part-time role for the Royals this season. Prior to his suspension, he appeared in 53 games, hitting .288 with three home runs and 20 RBIs.